AmerisourceBergen

presented by
presented by
News

Cardinal Health’s dependence on top customers leaves it ‘vulnerable’

Cardinal Health (NYSE:CAH) renewal of a key drug distribution contract with Walgreen Co. earlier this month brings renewed focus on just how heavily reliant Cardinal is on its top two customers. In Cardinal's fiscal 2010, Walgreen (24 percent) and CVS (22 percent) combined for a 46 percent share of revenues. That's up from a combined 43 percent in 2008. Adam Fein, a pharmaceutical industry consultant with Pembroke Consulting, stated on his blog Drug Channels: "The data show a company that's increasingly at the mercy of its two dominant customers."